183 related articles for article (PubMed ID: 15548374)
41. Influence of pH on the Cytotoxic Activity of Inositol Hexakisphosphate (IP6) in Prostate Cancer.
Betton B; Gannon PO; Koumakpayi IH; Diallo JS; Mes-Masson AM; Saad F
Front Oncol; 2011; 1():40. PubMed ID: 22655245
[TBL] [Abstract][Full Text] [Related]
42. Apoptotic effect of IP(6) was not enhanced by co-treatment with myo-inositol in prostate carcinoma PC3 cells.
Kim HJ; Jang YM; Kim H; Kwon YH
Nutr Res Pract; 2007; 1(3):195-9. PubMed ID: 20368938
[TBL] [Abstract][Full Text] [Related]
43. Inositol hexaphosphate suppresses growth and induces apoptosis in prostate carcinoma cells in culture and nude mouse xenograft: PI3K-Akt pathway as potential target.
Gu M; Roy S; Raina K; Agarwal C; Agarwal R
Cancer Res; 2009 Dec; 69(24):9465-72. PubMed ID: 19920184
[TBL] [Abstract][Full Text] [Related]
44. Inositol hexaphosphate downregulates both constitutive and ligand-induced mitogenic and cell survival signaling, and causes caspase-mediated apoptotic death of human prostate carcinoma PC-3 cells.
Gu M; Raina K; Agarwal C; Agarwal R
Mol Carcinog; 2010 Jan; 49(1):1-12. PubMed ID: 19544333
[TBL] [Abstract][Full Text] [Related]
45. Role of inositol polyphosphates in programmed cell death.
Agarwal R; Mumtaz H; Ali N
Mol Cell Biochem; 2009 Aug; 328(1-2):155-65. PubMed ID: 19322641
[TBL] [Abstract][Full Text] [Related]
46. p21/Cip1 and p27/Kip1 Are essential molecular targets of inositol hexaphosphate for its antitumor efficacy against prostate cancer.
Roy S; Gu M; Ramasamy K; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
Cancer Res; 2009 Feb; 69(3):1166-73. PubMed ID: 19176374
[TBL] [Abstract][Full Text] [Related]
47. Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors.
Diallo JS; Betton B; Parent N; Péant B; Lessard L; Le Page C; Bertrand R; Mes-Masson AM; Saad F
Br J Cancer; 2008 Nov; 99(10):1613-22. PubMed ID: 18941459
[TBL] [Abstract][Full Text] [Related]
48. Chemopreventive efficacy of inositol hexaphosphate against prostate tumor growth and progression in TRAMP mice.
Raina K; Rajamanickam S; Singh RP; Agarwal R
Clin Cancer Res; 2008 May; 14(10):3177-84. PubMed ID: 18483386
[TBL] [Abstract][Full Text] [Related]
49. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells.
Karmakar S; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2094-102. PubMed ID: 17616815
[TBL] [Abstract][Full Text] [Related]
50. A review of the past, present, and future directions of neoplasia.
Rehemtulla A; Ross BD
Neoplasia; 2005 Dec; 7(12):1039-46. PubMed ID: 16354585
[No Abstract] [Full Text] [Related]
51. Prostate cancer and inositol hexaphosphate: efficacy and mechanisms.
Singh RP; Agarwal R
Anticancer Res; 2005; 25(4):2891-903. PubMed ID: 16080543
[TBL] [Abstract][Full Text] [Related]
52. Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents.
Agarwal R
Biochem Pharmacol; 2000 Oct; 60(8):1051-9. PubMed ID: 11007941
[TBL] [Abstract][Full Text] [Related]
53. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374
[TBL] [Abstract][Full Text] [Related]
54. Inositol hexaphosphate inhibits growth, and induces G1 arrest and apoptotic death of prostate carcinoma DU145 cells: modulation of CDKI-CDK-cyclin and pRb-related protein-E2F complexes.
Singh RP; Agarwal C; Agarwal R
Carcinogenesis; 2003 Mar; 24(3):555-63. PubMed ID: 12663518
[TBL] [Abstract][Full Text] [Related]
55. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
Zi X; Grasso AW; Kung HJ; Agarwal R
Cancer Res; 1998 May; 58(9):1920-9. PubMed ID: 9581834
[TBL] [Abstract][Full Text] [Related]
56. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
Tsihlias J; Zhang W; Bhattacharya N; Flanagan M; Klotz L; Slingerland J
Oncogene; 2000 Feb; 19(5):670-9. PubMed ID: 10698512
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
